Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 328

1.

Analysis of Trends in Insulin Utilization and Spending Across Canada From 2010 to 2015.

Xu Y, Gomes T, Mamdani MM, Juurlink DN, Cadarette SM, Tadrous M.

Can J Diabetes. 2018 Aug 16. pii: S1499-2671(18)30200-4. doi: 10.1016/j.jcjd.2018.08.190. [Epub ahead of print]

PMID:
30545737
2.

Lofexidine for Opioid Withdrawal: Small Effects at an Exorbitant Price.

Juurlink DN.

J Addict Med. 2018 Nov 29. doi: 10.1097/ADM.0000000000000473. [Epub ahead of print] No abstract available.

PMID:
30531233
3.

High-strength opioid formulations: the case for a ministerial recall.

Herder M, Juurlink D.

CMAJ. 2018 Dec 3;190(48):E1404-E1405. doi: 10.1503/cmaj.181289. No abstract available.

PMID:
30510044
4.

International Stakeholder Community of Pain Experts and Leaders Call for an Urgent Action on Forced Opioid Tapering.

Darnall BD, Juurlink D, Kerns RD, Mackey S, Van Dorsten B, Humphreys K, Gonzalez-Sotomayor JA, Furlan A, Gordon AJ, Gordon DB, Hoffman DE, Katz J, Kertesz SG, Satel S, Lawhern RA, Nicholson KM, Polomano RC, Williamson OD, McAnally H, Kao MC, Schug S, Twillman R, Lewis TA, Stieg RL, Lorig K, Mallick-Searle T, West RW, Gray S, Ariens SR, Sharpe Potter J, Cowan P, Kollas CD, Laird D, Ingle B, Julian Grove J, Wilson M, Lockman K, Hodson F, Palackdharry CS, Fillingim RB, Fudin J, Barnhouse J, Manhapra A, Henson SR, Singer B, Ljosenvoor M, Griffith M, Doctor JN, Hardin K, London C, Mankowski J, Anderson A, Ellsworth L, Davis Budzinski L, Brandt B, Harkootley G, Nickels Heck D, Zobrosky MJ, Cheek C, Wilson M, Laux CE, Datz G, Dunaway J, Schonfeld E, Cady M, LeDantec-Boswell T, Craigie M, Sturgeon J, Flood P, Giummarra M, Whelan J, Thorn BE, Martin RL, Schatman ME, Gregory MD, Kirz J, Robinson P, Marx JG, Stewart JR, Keck PS, Hadland SE, Murphy JL, Lumley MA, Brown KS, Leong MS, Fillman M, Broatch JW, Perez A, Watford K, Kruska K, Sophia You D, Ogbeide S, Kukucka A, Lawson S, Ray JB, Wade Martin T, Lakehomer JB, Burke A, Cohen RI, Grinspoon P, Rubenstein MS, Sutherland S, Walters K RN (Retired), Lovejoy T.

Pain Med. 2018 Nov 29. doi: 10.1093/pm/pny228. [Epub ahead of print] No abstract available.

PMID:
30496540
5.

Extracorporeal treatment in salicylate poisoning.

Hoffman RS, Juurlink DN, Ghannoum M, Nolin TD, Lavergne V, Gosselin S.

Clin Toxicol (Phila). 2018 Oct 11:1-2. doi: 10.1080/15563650.2018.1517882. [Epub ahead of print] No abstract available.

PMID:
30307333
6.

Studying Drug Safety in the Real World.

Zipursky J, Juurlink DN.

JAMA Intern Med. 2018 Nov 1;178(11):1533-1534. doi: 10.1001/jamainternmed.2018.5766. No abstract available.

PMID:
30304435
7.

Interprovincial Variation of Psychotropic Prescriptions Dispensed to Older Canadian Adults.

Black CD, McCarthy L, Gomes T, Mamdani M, Juurlink D, Tadrous M.

Can Geriatr J. 2018 Sep 30;21(3):269-273. doi: 10.5770/cgj.21.307. eCollection 2018 Sep.

8.

Contributions of prescribed and non-prescribed opioids to opioid related deaths: population based cohort study in Ontario, Canada.

Gomes T, Khuu W, Martins D, Tadrous M, Mamdani MM, Paterson JM, Juurlink DN.

BMJ. 2018 Aug 29;362:k3207. doi: 10.1136/bmj.k3207.

9.

Pregabalin and the Risk for Opioid-Related Death: A Nested Case-Control Study.

Gomes T, Greaves S, van den Brink W, Antoniou T, Mamdani MM, Paterson JM, Martins D, Juurlink DN.

Ann Intern Med. 2018 Nov 20;169(10):732-734. doi: 10.7326/M18-1136. Epub 2018 Aug 21. No abstract available.

PMID:
30140853
10.

Comparing the contribution of prescribed opioids to opioid-related hospitalizations across Canada: A multi-jurisdictional cross-sectional study.

Gomes T, Khuu W, Craiovan D, Martins D, Hunt J, Lee K, Tadrous M, Mamdani MM, Paterson JM, Juurlink DN.

Drug Alcohol Depend. 2018 Oct 1;191:86-90. doi: 10.1016/j.drugalcdep.2018.06.028. Epub 2018 Jul 31.

11.

Second-generation anti-depressants and risk of new-onset seizures in the elderly.

Finkelstein Y, Macdonald EM, Li P, Mamdani MM, Gomes T, Juurlink DN.

Clin Toxicol (Phila). 2018 Jul 10:1-6. doi: 10.1080/15563650.2018.1483025. [Epub ahead of print]

PMID:
29989445
12.

Depression in chronic pain: might opioids be responsible?

Mazereeuw G, Sullivan MD, Juurlink DN.

Pain. 2018 Nov;159(11):2142-2145. doi: 10.1097/j.pain.0000000000001305. No abstract available.

PMID:
29905651
13.

A population-based study of the risk of osteoporosis and fracture with dutasteride and finasteride.

Antoniou T, Macdonald EM, Yao Z, Gomes T, Tadrous M, Ho JM, Mamdani MM, Juurlink DN; Canadian Drug Safety and Effectiveness Research Network.

BMC Musculoskelet Disord. 2018 May 22;19(1):160. doi: 10.1186/s12891-018-2076-9.

14.

Clinical indications associated with opioid initiation for pain management in Ontario, Canada: a population-based cohort study.

Pasricha SV, Tadrous M, Khuu W, Juurlink DN, Mamdani MM, Paterson JM, Gomes T.

Pain. 2018 Aug;159(8):1562-1568. doi: 10.1097/j.pain.0000000000001242.

15.

Debating the opioid guidelines: context.

Busse JW, Juurlink D, Buckley DN, Guyatt GH.

Can Fam Physician. 2018 May;64(5):330-331. No abstract available.

16.

Debating the opioid guidelines: corrections.

Busse JW, Juurlink D, Buckley DN, Guyatt GH.

Can Fam Physician. 2018 May;64(5):328-330. No abstract available.

17.

Measuring the Burden of Opioid-related Mortality in Ontario, Canada.

Gomes T, Greaves S, Tadrous M, Mamdani MM, Paterson JM, Juurlink DN.

J Addict Med. 2018 Sep/Oct;12(5):418-419. doi: 10.1097/ADM.0000000000000412. No abstract available.

18.

Publicly Funded Oral Chronic Hepatitis B Treatment Patterns in Ontario over 16 Years: An Ecologic Study.

Tadrous M, Brahmania M, Martins D, Knowles S, Janssen HLA, Mamdani MM, Juurlink DN, Gomes T.

J Manag Care Spec Pharm. 2018 May;24(5):464-468. doi: 10.18553/jmcp.2018.24.5.464.

19.

Critiquing the CDC Opioid Guideline: Some Light From the Heat.

Juurlink DN.

Clin Pharmacol Ther. 2018 Jun;103(6):966-968. doi: 10.1002/cpt.1061. Epub 2018 Mar 30.

PMID:
29603206
20.

Catastrophic drug coverage: utilization insights from the Ontario Trillium Drug Program.

Tadrous M, Greaves S, Martins D, Mamdani MM, Juurlink DN, Gomes T.

CMAJ Open. 2018 Mar 14;6(1):E132-E138. doi: 10.9778/cmajo.20170132.

21.

The authors respond to "The 2017 Canadian opioid guideline: already time for an overhaul".

Busse JW, Juurlink D, Buckley DN, Guyatt GH.

CMAJ. 2018 Mar 12;190(10):E301. doi: 10.1503/cmaj.68675. No abstract available.

PMID:
29530874
22.

Fluoroquinolones and the aorta.

Juurlink DN.

BMJ. 2018 Mar 8;360:k988. doi: 10.1136/bmj.k988. No abstract available.

PMID:
29519782
23.

Argyria caused by chronic ingestion of silver.

Bracey NA, Zipursky JS, Juurlink DN.

CMAJ. 2018 Feb 5;190(5):E139. doi: 10.1503/cmaj.171374. No abstract available.

PMID:
29431112
24.

Publicly funded overactive bladder drug treatment patterns in Ontario over 15 years: An ecological study.

Tadrous M, Elterman D, Khuu W, Mamdani MM, Juurlink DN, Gomes T.

Can Urol Assoc J. 2018 Mar;12(3):E142-E145. doi: 10.5489/cuaj.4541. Epub 2017 Dec 22.

25.

Prior Authorization and Canadian Public Utilization of Direct-Acting Oral Anticoagulants.

Gao L, Tadrous M, Knowles S, Mamdani M, Paterson JM, Juurlink D, Gomes T.

Healthc Policy. 2017 Nov;13(2):68-78.

26.

Challenges Interpreting Chemoprevention Studies Using Observational Data.

Nayan M, Juurlink DN, Finelli A, Kulkarni G, Hamilton RJ.

J Clin Oncol. 2018 Feb 20;36(6):628-629. doi: 10.1200/JCO.2017.76.1064. Epub 2017 Dec 20. No abstract available.

PMID:
29261441
27.

Medication use and kidney cancer survival: A population-based study.

Nayan M, Juurlink DN, Austin PC, Macdonald EM, Finelli A, Kulkarni GS, Hamilton RJ; Canadian Drug Safety and Effectiveness Research Network (CDSERN).

Int J Cancer. 2018 May 1;142(9):1776-1785. doi: 10.1002/ijc.31204. Epub 2018 Jan 3.

PMID:
29226327
28.

Impact of a Graduated Approach on Opioid Initiation and Loss of Earnings Following Workplace Injury: A Time Series Analysis.

Gomes T, Duesburry J, Theriault ME, Bain D, Singh S, Martins D, Juurlink DN.

J Occup Environ Med. 2017 Dec;59(12):1197-1201. doi: 10.1097/JOM.0000000000001187.

29.

Availability of naloxone in Canadian pharmacies:a population-based survey.

Cressman AM, Mazereeuw G, Guan Q, Jia W, Gomes T, Juurlink DN.

CMAJ Open. 2017 Nov 8;5(4):E779-E784. doi: 10.9778/cmajo.20170123.

30.

Impact of Injectable Furosemide Hospital Shortage on Congestive Heart Failure Outcomes: A Time Series Analysis.

Tan VS, Nash DM, McArthur E, Jain AK, Garg AX, Juurlink DN, Weir MA.

Can J Cardiol. 2017 Nov;33(11):1498-1504. doi: 10.1016/j.cjca.2017.09.003. Epub 2017 Sep 12.

PMID:
29111110
31.

Real-world health care utilization and effectiveness of omalizumab for the treatment of severe asthma.

Tadrous M, Khuu W, Lebovic G, Stanbrook MB, Martins D, Paterson JM, Mamdani MM, Juurlink DN, Gomes T.

Ann Allergy Asthma Immunol. 2018 Jan;120(1):59-65.e2. doi: 10.1016/j.anai.2017.08.016. Epub 2017 Oct 3.

PMID:
28986124
32.

Gabapentin, opioids, and the risk of opioid-related death: A population-based nested case-control study.

Gomes T, Juurlink DN, Antoniou T, Mamdani MM, Paterson JM, van den Brink W.

PLoS Med. 2017 Oct 3;14(10):e1002396. doi: 10.1371/journal.pmed.1002396. eCollection 2017 Oct.

33.

The authors respond to "Inconsistencies in the 2017 Canadian Guideline for Opioids for Chronic Noncancer Pain".

Busse JW, Juurlink DN, Buckley DN, Guyatt GH.

CMAJ. 2017 Oct 2;189(39):E1234-E1235. doi: 10.1503/cmaj.733313. No abstract available.

34.

Rethinking "doing well" on chronic opioid therapy.

Juurlink DN.

CMAJ. 2017 Oct 2;189(39):E1222-E1223. doi: 10.1503/cmaj.170628. Review. No abstract available.

35.

Prevalence and characteristics of opioid-related deaths involving alcohol in Ontario, Canada.

Gomes T, Juurlink DN, Mamdani MM, Paterson JM, van den Brink W.

Drug Alcohol Depend. 2017 Oct 1;179:416-423. doi: 10.1016/j.drugalcdep.2017.07.008. Epub 2017 Aug 5.

PMID:
28867560
36.

Maternal infection can cause spontaneous abortion.

Zipursky JS, Cressman A, Juurlink DN.

CMAJ. 2017 Aug 8;189(31):E1021. doi: 10.1503/cmaj.733203. No abstract available.

37.

Medication use and kidney cancer risk: A population-based study.

Nayan M, Juurlink DN, Austin PC, Macdonald EM, Finelli A, Kulkarni GS, Hamilton RJ; Canadian Drug Safety and Effectiveness Research Network (CDSERN).

Eur J Cancer. 2017 Sep;83:203-210. doi: 10.1016/j.ejca.2017.07.001. Epub 2017 Jul 24.

PMID:
28750272
38.

The value of complementing administrative data with abstracted information on smoking and obesity: A study in kidney cancer.

Nayan M, Hamilton RJ, Finelli A, Austin PC, Kulkarni GS, Juurlink DN.

Can Urol Assoc J. 2017 Jun;11(6):167-171. doi: 10.5489/cuaj.4569.

39.

Pregabalin and heart failure: A population-based study.

Ho JM, Macdonald EM, Luo J, Gomes T, Antoniou T, Mamdani MM, Juurlink DN.

Pharmacoepidemiol Drug Saf. 2017 Sep;26(9):1087-1092. doi: 10.1002/pds.4239. Epub 2017 Jun 16.

PMID:
28620909
40.

Lipophilic Statins and the Risk of Intracranial Hemorrhage Following Ischemic Stroke: A Population-Based Study.

Quinn KL, Macdonald EM, Mamdani MM, Diong C, Juurlink DN; Canadian Drug Safety and Effectiveness Research Network (CDSERN).

Drug Saf. 2017 Oct;40(10):887-893. doi: 10.1007/s40264-017-0552-z.

PMID:
28620871
41.

Critical appraisal of the application of propensity score methods in the urology literature.

Nayan M, Hamilton RJ, Juurlink DN, Finelli A, Kulkarni GS, Austin PC.

BJU Int. 2017 Dec;120(6):873-880. doi: 10.1111/bju.13930. Epub 2017 Jul 7.

42.

Loperamide abuse.

Antoniou T, Juurlink DN.

CMAJ. 2017 Jun 12;189(23):E803. doi: 10.1503/cmaj.161421. No abstract available.

43.

A 1980 Letter on the Risk of Opioid Addiction.

Leung PTM, Macdonald EM, Stanbrook MB, Dhalla IA, Juurlink DN.

N Engl J Med. 2017 Jun 1;376(22):2194-2195. doi: 10.1056/NEJMc1700150. No abstract available.

PMID:
28564561
44.

Clinical Review: Loperamide Toxicity.

Wu PE, Juurlink DN.

Ann Emerg Med. 2017 Aug;70(2):245-252. doi: 10.1016/j.annemergmed.2017.04.008. Epub 2017 May 13. Review.

PMID:
28506439
45.

Intubation and salicylate overdose.

Gosselin S, Wang JJ, Villeneuve E, Juurlink D, Hoffman RS.

Am J Emerg Med. 2017 Aug;35(8):1193. doi: 10.1016/j.ajem.2017.04.074. Epub 2017 Apr 29. No abstract available.

PMID:
28495030
46.

Comment on Shively et al. "Acute salicylate poisoning: risk factors for severe outcome".

Zipursky J, Juurlink DN.

Clin Toxicol (Phila). 2017 Jul;55(6):609. doi: 10.1080/15563650.2017.1290254. Epub 2017 Feb 17. No abstract available.

PMID:
28489463
47.

Guideline for opioid therapy and chronic noncancer pain.

Busse JW, Craigie S, Juurlink DN, Buckley DN, Wang L, Couban RJ, Agoritsas T, Akl EA, Carrasco-Labra A, Cooper L, Cull C, da Costa BR, Frank JW, Grant G, Iorio A, Persaud N, Stern S, Tugwell P, Vandvik PO, Guyatt GH.

CMAJ. 2017 May 8;189(18):E659-E666. doi: 10.1503/cmaj.170363. No abstract available.

48.

Opioid Overuse or NSAID Underuse? A Response to the Pain Guide.

Hiremath S, Goldfarb DS, Juurlink DN.

Am J Kidney Dis. 2017 Jun;69(6):865. doi: 10.1053/j.ajkd.2017.02.375. Epub 2017 Apr 25. No abstract available.

PMID:
28454686
49.

Macrolides, Digoxin Toxicity and the Risk of Sudden Death: A Population-Based Study.

Quinn KL, Macdonald EM, Gomes T, Mamdani MM, Huang A, Juurlink DN; Canadian Drug Safety and Effectiveness Research Network (CDSERN).

Drug Saf. 2017 Sep;40(9):835-840. doi: 10.1007/s40264-017-0539-9.

PMID:
28421551
50.

Response to "Clarification from the College of Physicians and Surgeons of BC on commentary about limitations of the CDC guideline for prescribing opioids".

Busse JW, Juurlink D, Guyatt GH.

CMAJ. 2017 Apr 3;189(13):E509. doi: 10.1503/cmaj.732910. No abstract available.

Supplemental Content

Loading ...
Support Center